Current Clinical Trials

Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Janssen
Indentifier #: NCT01830543
Title: An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention, PIONEER AF-PCI
Department: Cardiology
Diagnosis: Cardiac - Acute Coronary Syndrome
Principal Investigator: Sporn M.D., Daniel
Sub-Investigator(s):
Sponsor: Yale
Indentifier #: NCT01755052
Title: Risk Stratification in Older Patients with Acute Myocardial Infarction: SILVER-AMI.
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lynch MD, Cynthia A.
Sponsor: Celldex
Indentifier #: NCT01997333
Title: CDX011-04, A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer
Department: Oncology
Diagnosis: Cancer Control
Principal Investigator: Srivatana M.D., Panit
Sponsor: Alexion
Indentifier #: NCT01374360
Title: Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry
Department: Cardiology
Diagnosis: Cardiac - Acute Coronary Syndrome
Principal Investigator: Venkatesh M.D., Govindarajan
Sponsor: Zoll
Indentifier #: NCT01446965
Title: Brief Title: Vest Prevention of Early Sudden Death Trial and VEST Registry Official Title: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: McDonald M.D., Thomas
Sponsor: Janssen
Indentifier #: none
Title: Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophogeal reflux disease and other gastrointestinal motility disorders. CIS-USA-154
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson M.D., Michael
Sponsor: Salix
Indentifier #: NCT02240121
Title: A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional Study to Assess the Efficacy and Safety of Rifaximin Delayed Release Tablets for the Induction and Maintenance of Remission in Subjects with Active Moderate Crohn's Disease (RECD3125)
Department: Family Practice
Diagnosis: Infectious Disease
Principal Investigator:
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT00665561
Title: An International, Multicenter, Prospective Observational Study Of The Safety Of Maraviroc Used With Optimized Background Therapy In Treatment-Experienced HIV-1 Infected Patients
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Srivatana M.D., Ukorn
Sponsor: Cubist
Indentifier #: NCT01598311
Title: LCD-CDAD-11-06 entitled, "A RANDOMIZED, DOUBLE-BLINDED, ACTIVE-CONTROLLED STUDY OF CB-183,315 IN PATIENTS WITH CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA" CUBIST
Department: Oncology
Diagnosis: Gastrointestinal - Pancreas
Principal Investigator: Lash MD, Bradley
Sponsor: RTOG
Indentifier #: NCT01013649
Title: RTOG0848, A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma